Interviews

Dustin Robinson, Founder of psychedelic VC firm Iter Investments, recently sat down with InvestorPlace to discuss the emerging sector of psychedelic medicine. Here are some key takeaways: When asked about the possible breadth of clinical psychedelics, Robinson had this to say: The FDA responds to data. People respond to stories Large institutions like the FDA…

Psychedelic Invest previously sat down with Psilera’s co-founder and CEO Chris Witowski in October 14, 2020. Now, nearly a year later, and having raised $2.5 million from investors including Iter Investments, Baird, JLS Fund, Receptor, and What If Ventures, we wanted to get an update on the company.  This time, we sat down with Jackie…

Around the world, conversations about psychedelic medicine are starting to infiltrate everyday life. Major universities and nonprofits are funding groundbreaking research, private companies are raising hundreds of millions of dollars, and an entire new way to approach mental health is starting to materialize. However, despite much of this progress, psychedelic drugs are still viewed with…

This morning, Monday May 24th, Enveric Biosciences (NASDAQ: ENVB) announced that it has entered an agreement to acquire privately held biotechnology company MagicMed Industries. MagicMed has a state-of-the-art facility at the University of Calgary, which it uses to perform extensive R&D on naturally occurring psychedelic molecules. Their focus is the discovery and early development of…